Haleon Starts Standalone Life By Raising Sales Expectations
A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.
A better than expected first-half performance has put Haleon on a sure footing for the rest of the year following its recent demerger from GSK.